The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase 2 prospective trial of cabozantinib as first-line treatment for metastatic collecting ducts renal cell carcinoma: The BONSAI trial (Meeturo 2) clinical trial information—NCT03354884.
 
Giuseppe Procopio
Consulting or Advisory Role - Astellas Pharma; Bayer; Bristol-Myers Squibb (BMS); Ipsen; Janssen; Merck Sharp & Dohme; Novartis; Pfizer
 
Pierangela Sepe
No Relationships to Disclose
 
Sebastiano Buti
No Relationships to Disclose
 
Melanie Claps
No Relationships to Disclose
 
Maurizio Colecchia
No Relationships to Disclose
 
Loris De Cecco
No Relationships to Disclose
 
Devecchi Andrea
No Relationships to Disclose
 
Matteo Dugo
No Relationships to Disclose
 
Chiara Gargiuli
No Relationships to Disclose
 
Patrizia Giannatempo
No Relationships to Disclose
 
Valentina Guadalupi
No Relationships to Disclose
 
Luigi Mariani
No Relationships to Disclose
 
Arianna Ottini
No Relationships to Disclose
 
Marialuisa Sensi
No Relationships to Disclose
 
Filippo G. De Braud
Honoraria - BMS; Merck; MSD; Pfizer; Roche; Sanofi; SERVIER
Consulting or Advisory Role - Bristol-Myers Squibb; EMD SERONO; Incyte; Nerviano Medical Sciences; Novartis Italy; Roche; Sanofi; Teofarma
Research Funding - Kymab (Inst); Loxo (Inst); Merck Serono (Inst); Nerviano Medical Sciences (Inst); Novartis (Inst); Pfizer (Inst); Philogen (Inst); Roche (Inst); SERVIER (Inst); Tesaro (Inst)
 
Elena Verzoni
Consulting or Advisory Role - Janssen
Speakers' Bureau - Astellas Amgen BioPharama; Ipsen; Janssen; MSD; Novartis; Pfizer